全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Phenotypic Characterization of Klebsiella Producing Extended-Spectrum β-Lactamases and Carbapenemases in Three Referral Hospitals in the City of Yaounde, Cameroon

DOI: 10.4236/ojmm.2026.162005, PP. 82-100

Keywords: Klebsiella spp., Resistance Phenotypes, ESBL, Carbapenemases

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Antimicrobial resistance has become a major public health threat globally. The resistance mechanisms of Klebsiella include the production of extended-spectrum beta-lactamases (ESBLs) and carbapenemases, limiting the effectiveness of standard treatments. Objectives: The main objective of this study was to carry out the phenotypic characterization of β-lactam-resistant Klebsiella strains isolated from blood, pus and urine in three referral hospitals in the city of Yaounde. Methods: This was a cross-sectional study. Data collection was carried out over a one-year period from January to December 2023 in the bacteriology laboratories of three referral hospitals in Yaounde: Yaounde University Teaching Hospital (YUTH), Yaounde General Hospital, Yaounde Gynecological-Obstetric and Pediatric Hospital. Antimicrobial susceptibility testing by the disc diffusion method in accordance with the Antibiogram Committee of the French Society of Microbiology made the identification of the different resistance phenotypes possible. Results: Of the 264 clinical specimens analyzed, majority were from female patients, n = 135 (51.1%). The clinical specimens analyzed were urine, suppuration and blood (39.8%, 31.4% and 28.8% respectively). Klebsiella pneumoniae pneumoniae was the most frequently isolated subspecies (62.2%). The antibiotic susceptibility study showed an overall predominance of resistant strains with high rates of resistance to cefalexin, cefixime, ceftriaxone and cefotaxime (75.4%; 74.7%; 73.0% and 72.1% respectively). However, imipenem, meropenem, ceftazidime/avibactam and ertapenem were the most effective molecules against the Klebsiella species tested, with resistance rates of 10.6%, 14.3%, 21.7% and 30.4%, respectively. Phenotypic tests revealed the predominance of the following resistant phenotypes among the strains: extended-spectrum β-lactamase (42.4%), low-level/wild-type penicillinase (20.1%), derepressed penicillinase (3.0%), carbapenemases (33.7%) and high-level cephalosporinase (4.9%). Taking into consideration of the “screening carbapenemase-producing strains” algorithm, 89 isolates were suspected of producing carbapenemase, representing 33.7% of our isolates. Conclusion: Our findings demonstrate the circulation of strains with worrying resistance phenotypes, highlighting the urgent need for action by the Cameroonian health authorities.

References

[1]  Song, H.-W., Lin, Y., Wan, T., Yang, G., Jiang, M., Fu, B., et al. (2025) Global Burden of Klebsiella pneumoniae Infections and Antimicrobial Resistance in 2019. BMC Infectious Diseases, 25, Article No. 1773.
https://doi.org/10.1186/s12879-025-12120-w
[2]  OMS (2025) L’OMS met en garde contre une résistance généralisée aux antibiotiques courants dans le monde.
https://www.who.int/fr/news/item/13-10-2025-who-warns-of-widespread-resistance-to-common-antibiotics-worldwide
[3]  Samia, A. and Soumia, M. (2022) Etude bibliographique sur Klebsiella pneumoniae: Virulence et résistance aux antibiotiques.
[4]  Jiang, W., Yang, W., Zhao, X., Wang, N. and Ren, H. (2020) Klebsiella pneumoniae Presents Antimicrobial Drug Resistance for β-Lactam through the ESBL/PBP Signaling Pathway. Experimental and Therapeutic Medicine, 19, 2449-2456.
https://doi.org/10.3892/etm.2020.8498
[5]  European Centre for Disease Prevention and Control (2023) Carbapenem-and/or Colistin-Resistant Klebsiella pneumoniae in Greece: Molecular Follow-Up Survey 2022.
https://www.ecdc.europa.eu/en/publications-data/carbapenem-andor-colistin-resistant-klebsiella-pneumoniae-greece-molecular-follow?utm_source
[6]  OMS (2024) L’OMS met à jour la liste des bactéries résistantes aux médicaments qui représentent la plus grande menace pour la santé humaine.
https://www.who.int/fr/news/item/17-05-2024-who-updates-list-of-drug-resistant-bacteria-most-threatening-to-human-health
[7]  Kenkouo, G.A. (2008) Etude bactériologique des infections urinaires au Centre Pasteur du Cameroun. Memoire Online.
https://www.memoireonline.com/07/08/1233/m_etude-bacteriologie-infections-urinaires-centre-pasteur-cameroun.html
[8]  Mbamyah, E.E.L., Kumcho, M.P., Toukam, M., Sedena, D., Enyeji, F.A., Teukam, A., et al. (2024) Phenotypic Characterization of Extended Spectrum Beta-Lactamase, Class C Cephalosporinase and Carbapenemase-Producing Klebsiella Species Isolated from Patients Consulted at Four Yaounde-Based Hospitals. Open Journal of Medical Microbiology, 14, 105-119.
https://doi.org/10.4236/ojmm.2024.142009
[9]  Ebongue, C.O., Tsiazok, M.D., Nda, J.P., Ngaba, G.P., Beyiha, G. and Adiogo, D. (2015) Evolution de la résistance aux antibiotiques des entérobactéries isolées à l’h?pital général de douala de 2005 à 2012. Pan African Medical Journal, 20, Article 227.
https://doi.org/10.11604/pamj.2015.20.227.4770
[10]  Livermore, D.M. (1995) Beta-Lactamases in Laboratory and Clinical Resistance. Clinical Microbiology Reviews, 8, 557-584.
https://doi.org/10.1128/cmr.8.4.557
[11]  Podschun, R. and Ullmann, U. (1998) Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clinical Microbiology Reviews, 11, 589-603.
https://doi.org/10.1128/cmr.11.4.589
[12]  Mbamyah, E.E.L., Toukam, M., Assoumou, M.O., Smith, A.M., Nkenfou, C., Gonsu, H.K., et al. (2020) Genotypic Diversity and Characterization of Quinolone Resistant Determinants from Enterobacteriaceae in Yaoundé, Cameroon. Open Journal of Medical Microbiology, 10, 33-45.
https://doi.org/10.4236/ojmm.2020.102004
[13]  Mbamyah, E.E.L., Enyeji, F.A., Torimiro, J., Mangum, P., Djuissi, M., Teukam, A., et al. (2021) High Prevalence of Multidrug Resistant Klebsiella Species Isolated from the Yaounde University Teaching Hospital, Cameroon. Open Journal of Medical Microbiology, 11, 91-99.
https://doi.org/10.4236/ojmm.2021.112008
[14]  WHO (2022) Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2022.
https://www.who.int/publications/i/item/9789240062702
[15]  Paterson, D.L. and Bonomo, R.A. (2005) Extended-Spectrum Beta-Lactamases: A Clinical Update. Clinical Microbiology Reviews, 18, 657-686.
https://pubmed.ncbi.nlm.nih.gov/16223952/
[16]  Cantón, R., González-Alba, J.M. and Galán, J.C. (2012) CTX-M Enzymes: Origin and Diffusion. Frontiers in Microbiology, 3, Article 110.
https://doi.org/10.3389/fmicb.2012.00110
[17]  European Centre for Disease Prevention and Control (2025) Surveillance of Antimicrobial Resistance in Europe, 2024 Data.
https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2024-data
[18]  Poirel, L., He?ritier, C., Tolu?n, V. and Nordmann, P. (2004) Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 48, 15-22.
https://doi.org/10.1128/aac.48.1.15-22.2004
[19]  Nordmann, P., Naas, T. and Poirel, L. (2011) Global Spread of Carbapenemase-Producing Enterobacteriaceae. Emerging Infectious Diseases, 17, 1791-1798.
https://doi.org/10.3201/eid1710.110655
[20]  Betbeui, A., Kamga, H., Toukam, M., Mbakop, C., Lyonga, E., Bilong, S., et al. (2015) Phenotypic Detection of Extended Spectrum Beta-Lactamase and Carbapenemases Produced by Klebsiella spp. Isolated from Three Referrals Hospitals in Yaounde, Cameroon. British Microbiology Research Journal, 9, 1-9.
https://doi.org/10.9734/bmrj/2015/18250
[21]  Chafa, A.B., Mbamyah, E.L., Kamdjo, C.S., Abange, W.B., L., Y.N.C., Teudjieu, A.D., et al. (2024) Evolution of the Resistance Profile of Klebsiella Species to Antibiotics over Ten Years at the Yaoundé University Teaching Hospital, Cameroon. Microbiology Research Journal International, 34, 48-59.
https://doi.org/10.9734/mrji/2024/v34i111498
[22]  Kang, C.-I., Kim, S.-H., Park, W.B., Lee, K., Kim, H., Kim, E., et al. (2005) Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome. Antimicrobial Agents and Chemotherapy, 49, 760-766.
https://doi.org/10.1128/aac.49.2.760-766.2005
[23]  Bush, K. and Bradford, P.A. (2016) β-Lactams and β-Lactamase Inhibitors: An Overview. Cold Spring Harbor Perspectives in Medicine, 6, a025247.
https://doi.org/10.1101/cshperspect.a025247
[24]  Jacobson, K.L., Cohen, S.H., Inciardi, J.F., King, J.H., Lippert, W.E., Iglesias, T., et al. (1995) The Relationship between Antecedent Antibiotic Use and Resistance to Extended-Spectrum Cephalosporins in Group I β-Lactamase-Producing Organisms. Clinical Infectious Diseases, 21, 1107-1113.
https://doi.org/10.1093/clinids/21.5.1107
[25]  Gangoue?-Pie?boji, J., Bedenic, B., Koulla-Shiro, S., Randegger, C., Adiogo, D., Ngassam, P., et al. (2005) Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Yaounde, Cameroon. Journal of Clinical Microbiology, 43, 3273-3277.
https://doi.org/10.1128/jcm.43.7.3273-3277.2005
[26]  Lonchel, C.M., Meex, C., Gangoué-Piéboji, J., et al. (2012) Proportion of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community Setting in Ngaoundere, Cameroon. BMC Infectious Diseases, 12, Article No. 53.
https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-12-53
[27]  Akta?, Z., Kayacan, ?.B., Schneider, I., Can, B., Midilli, K. and Bauernfeind, A. (2008) Carbapenem-Hydrolyzing Oxacillinase, OXA-48, Persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy, 54, 101-106.
https://doi.org/10.1159/000118661
[28]  Cuzon, G., Naas, T., Lesenne, A., Benhamou, M. and Nordmann, P. (2010) Plasmid-mediated Carbapenem-Hydrolysing OXA-48 β-Lactamase in Klebsiella pneumoniae from Tunisia. International Journal of Antimicrobial Agents, 36, 91-93.
https://doi.org/10.1016/j.ijantimicag.2010.02.014
[29]  Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D.L., et al. (2018) Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis. The Lancet Infectious Diseases, 18, 318-327.
https://doi.org/10.1016/s1473-3099(17)30753-3
[30]  Vincent, J., Rello, J., Marshall, J., et al. (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA, 302, 2323-2329.
https://jamanetwork.com/journals/jama/fullarticle/184963
[31]  Logan, L.K. and Weinstein, R.A. (2017) The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. The Journal of Infectious Diseases, 215, S28-S36.
https://doi.org/10.1093/infdis/jiw282
[32]  Magill, S.S., Edwards, J.R., Bamberg, W., Beldavs, Z.G., Dumyati, G., Kainer, M.A., et al. (2014) Multistate Point-Prevalence Survey of Health Care-Associated Infections. New England Journal of Medicine, 370, 1198-1208.
https://doi.org/10.1056/nejmoa1306801

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133